717 related articles for article (PubMed ID: 30771783)
41. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
[TBL] [Abstract][Full Text] [Related]
42. The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgery.
Hong S; Bouchal SM; Bauman MMJ; Riviere-Cazaux C; Pumford AD; Brown PD; Yan ES; Stafford SL; Markovic SN; Link MJ; Burns TC; Jusue-Torres I; Pollock BE; Parney IF
J Neurosurg; 2024 Apr; 140(4):938-948. PubMed ID: 37878000
[TBL] [Abstract][Full Text] [Related]
43. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
44. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis.
Singh R; Bowden G; Mathieu D; Perlow HK; Palmer JD; Elhamdani S; Shepard M; Liang Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Elazzazi AH; Warnick RE; Gozal YM; Daly M; McShane B; Addis-Jackson M; Karthikeyan G; Smith S; Picozzi P; Franzini A; Kaisman-Elbaz T; Yang HC; Wei Z; Legarreta A; Hess J; Templeton K; Pikis S; Mantziaris G; Simonova G; Liscak R; Peker S; Samanci Y; Chiang V; Niranjan A; Kersh CR; Lee CC; Trifiletti DM; Lunsford LD; Sheehan JP
Neurosurgery; 2023 Sep; 93(3):592-598. PubMed ID: 36942965
[TBL] [Abstract][Full Text] [Related]
45. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review.
Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z
APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial.
Huff WX; Agrawal N; Shapiro S; Miller J; Kulwin C; Shah M; Savage JJ; Payner T; Vortmeyer A; Watson G; Dey M
Radiat Oncol; 2018 Dec; 13(1):252. PubMed ID: 30572923
[TBL] [Abstract][Full Text] [Related]
47. Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study.
Hartford AC; Gill GS; Ravi D; Tosteson TD; Li Z; Russo G; Eskey CJ; Jarvis LA; Simmons NE; Evans LT; Williams BB; Gladstone DJ; Roberts DW; Buckey JC
Radiother Oncol; 2022 Dec; 177():179-184. PubMed ID: 36404528
[TBL] [Abstract][Full Text] [Related]
48. Treatment and survival of patients with small cell lung cancer and brain metastasis.
Chiang CL; Yang HC; Liao YT; Luo YH; Wu YH; Wu HM; Chen YM
J Neurooncol; 2023 Nov; 165(2):343-351. PubMed ID: 37983003
[TBL] [Abstract][Full Text] [Related]
49. Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer.
Khalaveh F; Cho A; Shaltout A; Untersteiner H; Kranawetter B; Hirschmann D; Göbl P; Marik W; Gatterbauer B; Rössler K; Dorfer C; Frischer JM
Radiat Oncol; 2023 Dec; 18(1):197. PubMed ID: 38071299
[TBL] [Abstract][Full Text] [Related]
50. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract][Full Text] [Related]
51. Survival and outcomes in patients with ≥ 25 cumulative brain metastases treated with stereotactic radiosurgery.
Benjamin CG; Gurewitz J; Kavi A; Bernstein K; Silverman J; Mureb M; Donahue B; Kondziolka D
J Neurosurg; 2022 Aug; 137(2):571-581. PubMed ID: 34952524
[TBL] [Abstract][Full Text] [Related]
52. Long-term survival in patients with brain metastases-clinical characterization of a rare scenario.
Hügel M; Stöhr J; Kuhnt T; Nägler F; Papsdorf K; Klagges S; Hambsch P; Güresir E; Nicolay NH; Seidel C
Strahlenther Onkol; 2024 Apr; 200(4):335-345. PubMed ID: 37646818
[TBL] [Abstract][Full Text] [Related]
53. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
Albers EAC; de Ruiter MB; van de Poll-Franse LV; Merckel LG; Compter A; Schagen SB
J Neurooncol; 2022 Dec; 160(3):649-658. PubMed ID: 36454373
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
Dohm AE; Tang JD; Mills MN; Liveringhouse CL; Sandoval ML; Perez BA; Robinson TJ; Creelan BC; Gray JE; Etame AB; Vogelbaum MA; Forsyth P; Yu HM; Oliver DE; Ahmed KA
J Neurosurg; 2023 Jun; 138(6):1600-1607. PubMed ID: 36681988
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients.
Pennathur A; Luketich JD; Heron DE; Schuchert MJ; Bianco V; Clump D; Burton S; Abbas G; Gooding WE; Ozhasoglu C; Landreneau RJ; Christie NA
Ann Thorac Surg; 2015 Dec; 100(6):2019-24. PubMed ID: 26387725
[TBL] [Abstract][Full Text] [Related]
56. Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer.
Kumar A; Srinivasan D; Potter AL; Mathey-Andrews C; Lanuti M; Martin LW; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1895-1905.e2. PubMed ID: 37722622
[TBL] [Abstract][Full Text] [Related]
57. Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review.
Zamarud A; Marianayagam NJ; Sekar V; Testa S; Park DJ; Yener U; McCleary TL; Yoo KH; Emrich S; Tayag A; Ustrzynski L; Pollom E; Soltys S; Wang L; Charville G; Ganjoo K; Chang SD; Meola A
J Neurosurg Spine; 2024 Apr; 40(4):485-497. PubMed ID: 38157539
[TBL] [Abstract][Full Text] [Related]
58. Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?
Soike MH; Hughes RT; Farris M; McTyre ER; Cramer CK; Bourland JD; Chan MD
Neurosurgery; 2019 Mar; 84(3):558-566. PubMed ID: 29860451
[TBL] [Abstract][Full Text] [Related]
59. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract][Full Text] [Related]
60. Surgical management of non-small cell lung cancer with limited metastatic disease involving only the brain.
Kumar A; Kumar S; Potter AL; Raman V; Kozono DE; Lanuti M; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2024 Feb; 167(2):466-477.e2. PubMed ID: 37121537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
